Related Content
Search Google Scholar for:
|
|
Science 6 August 1971: Vol. 173. no. 3996, pp. 553 - 554 DOI: 10.1126/science.173.3996.553
|
|
Articles
C1 Inhibitor: Evidence for Decreased Hepatic Synthesis in Hereditary Angioneurotic Edema
A. Myron Johnson 1,
Chester A. Alper 2,
Fred S. Rosen 2, and
John M. Craig 3
1 Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill 27514
2 Department of Pediatrics, Harvard Medical School, and Blood Grouping Laboratory and Laboratory of Immunology, Children's Hospital Medical Center, Boston, Massachusetts 02115
3 Department of Pathology, Harvard Medical School, and Department of Pathology, Boston Hospital for Women, Boston, Massachusetts 02115
Although the Cl inhibitor was detected in 5 to 10 percent of normal hepatic parenchymal cells by means of the immunofluorescent technique, none was seen in liver biopsies from two individuals with hereditary angioneurotic edema having low concentrations of Cl inhibitor in the serum. In contrast, the percentages of cells which reacted with fluorescent antiserums to C4 and transferrin were normal. These data suggest that in most subjects with hereditary angioneurotic edema, there is decreased synthesis of the C1 inhibitor but normal synthesis of C4, and that the disease results from this biosynthetic error.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Hereditary angioedema and pregnancy: successful management of recurrent and frequent attacks of angioedema with C1-inhibitor concentrate, danazol and tranexamic acid - a case report.
- D S Milingos, P Madhuvrata, J Dean, A Shetty, and D M Campbell (2009)
Obstet Med
2, 123-125
| Abstract »
| Full Text »
| PDF »
- Complement Regulatory Protein C1 Inhibitor Binds to Selectins and Interferes with Endothelial-Leukocyte Adhesion.
- S. Cai and A. E. Davis III (2003)
J. Immunol.
171, 4786-4791
| Abstract »
| Full Text »
| PDF »
- In Vivo Biosynthesis of Endogenous and of Human C1 Inhibitor in Transgenic Mice: Tissue Distribution and Colocalization of Their Expression.
- G. Vinci, N. J. Lynch, C. Duponchel, T.-M. Lebastard, G. Milon, C. Stover, W. Schwaeble, and M. Tosi (2002)
J. Immunol.
169, 5948-5954
| Abstract »
| Full Text »
| PDF »
- Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency).
- A Fay and M Abinun (2002)
J. Clin. Pathol.
55, 266-270
| Abstract »
| Full Text »
| PDF »
- Danazol.
- A. E. MADANES and M. FARBER (1982)
Ann Intern Med
96, 625-630
| Abstract »
| PDF »
- Long-Term Therapy of Hereditary Angioedema with Danazol.
- S. W. HOSEA, M. L. SANTAELLA, E. J. BROWN, M. BERGER, K. KATUSHA, and M. M. FRANK (1980)
Ann Intern Med
93, 809-812
| Abstract »
| PDF »
- Methyltestosterone Therapy in Hereditary Angioedema.
- A. L. SHEFFER, D. T. FEARON, and K. F. AUSTEN (1977)
Ann Intern Med
86, 306-308
| Abstract »
| PDF »
- Hereditary Angioedema: the Clinical Syndrome and Its Management.
- M. M. FRANK, J. A. GELFAND, and J. P. ATKINSON (1976)
Ann Intern Med
84, 580-593
| Abstract »
| PDF »
- Kallikrein-Bradykinin System in Chronic Alcoholic Liver Disease.
- P. WONG, R. W. COLMAN, R. C. TALAMO, and B. M. BABIOR (1972)
Ann Intern Med
77, 205-209
| Abstract »
| PDF »
|
|